{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:40:27Z","timestamp":1760204427462},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Veterinary Journal"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.tvjl.2010.04.017","type":"journal-article","created":{"date-parts":[[2010,5,24]],"date-time":"2010-05-24T08:29:26Z","timestamp":1274689766000},"page":"75-82","source":"Crossref","is-referenced-by-count":5,"title":["Liver transcriptomic changes associated with ritonavir-induced hyperlipidemia in sensitive and resistant strains of rats"],"prefix":"10.1016","volume":"185","author":[{"given":"Yi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette J.","family":"Dahly-Vernon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric A.G.","family":"Blomme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lai-Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dale J.","family":"Kempf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kennan C.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvette A.","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven H.","family":"Nye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darin L.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J.","family":"Roman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Howard J.","family":"Jacob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey F.","family":"Waring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvjl.2010.04.017_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF02679998","article-title":"Disturbed lipid metabolism in glycogen storage disease type 1","volume":"161","author":"Bandsma","year":"2002","journal-title":"European Journal of Pediatrics"},{"key":"10.1016\/j.tvjl.2010.04.017_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.toxlet.2008.09.017","article-title":"Use of toxicogenomics to understand mechanisms of drug-induced hepatotoxicity during drug discovery and development","volume":"186","author":"Blomme","year":"2009","journal-title":"Toxicology Letters"},{"key":"10.1016\/j.tvjl.2010.04.017_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1568026013394949","article-title":"The new pre-preclinical paradigm: compound optimization in early and late phase drug discovery","volume":"1","author":"Caldwell","year":"2001","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"10.1016\/j.tvjl.2010.04.017_bib4","first-page":"233","article-title":"Histopathology of cholestasis","volume":"79","author":"Desmet","year":"1995","journal-title":"Verhandlungen der Deutschen Gesellschaft f\u00fcr Pathology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib5","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1086\/378131","volume":"37","author":"Dube","year":"2003","journal-title":"Clinical Infectious Disease"},{"key":"10.1016\/j.tvjl.2010.04.017_bib6","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1185\/030079902125000516","article-title":"Effects of fibrates on serum metabolic parameters","volume":"18","author":"Elisaf","year":"2002","journal-title":"Current Medical Research and Opinion"},{"key":"10.1016\/j.tvjl.2010.04.017_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11745-009-3369-4","article-title":"Lipid abnormalities in a never-treated HIV-1 subtype C-infected African population","volume":"45","author":"Fourie","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/j.tvjl.2010.04.017_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/oxfordjournals.jbchem.a123713","article-title":"Nutritional and hormonal regulation of mRNA levels of lipogenic enzymes in primary cultures of rat hepatocytes","volume":"111","author":"Fukuda","year":"1992","journal-title":"Journal of Biochemistry (Tokyo)"},{"key":"10.1016\/j.tvjl.2010.04.017_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1089\/088922203771881248","article-title":"HIV protease inhibitor ritonavir induces lipoatrophy in male mice","volume":"19","author":"Goetzman","year":"2003","journal-title":"AIDS Research and Human Retroviruses"},{"key":"10.1016\/j.tvjl.2010.04.017_bib10","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0163-7827(02)00046-2","article-title":"Effects of HIV protease inhibitor therapy on lipid metabolism","volume":"42","author":"Hui","year":"2003","journal-title":"Progress in Lipid Research"},{"key":"10.1016\/j.tvjl.2010.04.017_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0300-483X(00)00440-6","article-title":"Confounding factors in toxicity testing","volume":"160","author":"Kacew","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib12","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0960-0760(02)00071-7","article-title":"Half-life of cholesterol 7alpha-hydroxylase activity and enzyme mass differ in animals and humans when determined by a monoclonal antibody against human cholesterol 7alpha-hydroxylase","volume":"81","author":"Kinowaki","year":"2002","journal-title":"Journal of Steroid Biochemistry and Molecular Biology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbrc.2004.01.028","article-title":"Primary structure and inducibility by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) of aryl hydrocarbon receptor repressor in a TCDD-sensitive and a TCDD-resistant rat strain","volume":"315","author":"Korkalainen","year":"2004","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.tvjl.2010.04.017_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11904-996-0008-z","article-title":"The effects of HIV protease inhibitors on carbohydrate and lipid metabolism","volume":"2","author":"Lee","year":"2005","journal-title":"Current HIV\/AIDS Reports"},{"key":"10.1016\/j.tvjl.2010.04.017_bib15","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1161\/01.ATV.20.12.2625","article-title":"HIV protease inhibitors stimulate hepatic triglyceride synthesis","volume":"20","author":"Lenhard","year":"2000","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib16","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ygeno.2007.06.004","article-title":"Gene expression profiling of rat liver reveals a mechanistic basis for ritonavir-induced hyperlipidemia","volume":"90","author":"Lum","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.tvjl.2010.04.017_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0166-3542(98)00011-4","article-title":"Recent developments in HIV protease inhibitor therapy","volume":"39","author":"Molla","year":"1998","journal-title":"Antiviral Research"},{"key":"10.1016\/j.tvjl.2010.04.017_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/QAI.0b013e31806007ed","article-title":"Metabolic issues associated with protease inhibitors","volume":"45","author":"Moyle","year":"2007","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.tvjl.2010.04.017_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1080\/15216540400020387","article-title":"HIV protease inhibitors-induced atherosclerosis: prevention by alpha-tocopherol","volume":"56","author":"Munteanu","year":"2004","journal-title":"IUBMB Life"},{"key":"10.1016\/j.tvjl.2010.04.017_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2174\/156652407780059168","article-title":"Enzymes in the conversion of cholesterol into bile acids","volume":"7","author":"Norlin","year":"2007","journal-title":"Current Molecular Medicine"},{"key":"10.1016\/j.tvjl.2010.04.017_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1152\/ajpgi.2001.281.4.G878","article-title":"Effects of CYP7A1 overexpression on cholesterol and bile acid homeostasis","volume":"281","author":"Pandak","year":"2001","journal-title":"American Journal of Physiology Gastrointestinal and Liver Physiology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib22","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"Periard","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.tvjl.2010.04.017_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1172\/JCI0215387","article-title":"Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype","volume":"110","author":"Pullinger","year":"2002","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.tvjl.2010.04.017_bib24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0300-483X(95)03175-F","article-title":"Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague\u2013Dawley rats","volume":"106","author":"Reasor","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib25","doi-asserted-by":"crossref","first-page":"37514","DOI":"10.1074\/jbc.M104557200","article-title":"HIV protease inhibitor induces fatty acid and sterol biosynthesis in liver and adipose tissues due to the accumulation of activated sterol regulatory element-binding proteins in the nucleus","volume":"276","author":"Riddle","year":"2001","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.tvjl.2010.04.017_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/00126334-200310012-00005","article-title":"HIV, HAART, and hyperlipidemia: balancing the effects","volume":"34","author":"Sherer","year":"2003","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"10.1016\/j.tvjl.2010.04.017_bib27","first-page":"4","article-title":"Guiding principles in the use of animals in toxicology. Adopted by the Society of Toxicology in July 1989","volume":"178","author":"Society of Toxicology","year":"2002","journal-title":"Toxicology and Applied Pharmacology"},{"key":"10.1016\/j.tvjl.2010.04.017_bib28","doi-asserted-by":"crossref","first-page":"24053","DOI":"10.1074\/jbc.M401489200","article-title":"Identification of the CREB-binding protein\/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator","volume":"279","author":"Tien","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.tvjl.2010.04.017_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.qai.0000219774.20174.64","article-title":"Lopinavir\/ritonavir induces the hepatic activity of cytochrome P450 enzymes CYP2C9, CYP2C19, and CYP1A2 but inhibits the hepatic and intestinal activity of CYP3A as measured by a phenotyping drug cocktail in healthy volunteers","volume":"42","author":"Yeh","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"}],"container-title":["The Veterinary Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023310001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1090023310001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T04:13:44Z","timestamp":1635394424000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1090023310001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S1090023310001255"],"URL":"https:\/\/doi.org\/10.1016\/j.tvjl.2010.04.017","relation":{},"ISSN":["1090-0233"],"issn-type":[{"value":"1090-0233","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}